Soo Yeon Cheong

机构：Galderma (United States)

发表论文 34 篇 · 总被引 1073 次 · h-index 15

代表论文

• A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy (2015 · Annals of the Rheumatic Diseases · 被引 229)
• Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials (2024 · The Lancet · 被引 145)
• Phase III Randomized Study of SB 5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis (2017 · Arthritis & Rheumatology · 被引 133)
• Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4 (2017 · Annals of the Rheumatic Diseases · 被引 110)
• 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis (2017 · Lara D. Veeken · 被引 68)
• Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study (2017 · British Journal of Dermatology · 被引 32)